Saidal issued the following announcement on Feb. 10.
February 05, 2019 will remain in the annals of the SAIDAL Group, as the new Cherchell production site has been inspected by experts from the Ministry of Health, Population and Hospital Reform, for the launch the third batch of validation of two products.
After an inspection of the premises, the latter proceeded to the documentary control of the batch records and procedures of the products in question; namely LAVIDA R 2mg, and RHYDRAX R.
This event was marked by the presence of the Chairman and Chief Executive Officer, senior executives of the General Management, as well as the social partner.
It should be remembered that the purpose of this inspection is to obtain the decision to operate the site.
Original source: http://saidalgroup.dz/fr/actualites/item/1555-site-cherchell-vers-le-demarrage
